Skip to main content
SpringerLink
Log in

From Obesity to Diabetes

  • Book
  • © 2022

Overview

Editors:
  1. Juergen Eckel

    1. Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Karine Clément

    1. NutriOmique Research group, Nutrition Department, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université/INSERM, Paris, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Provides new insights into the pathophysiology of obesity
  • Deciphers the complex links to diabetes and its complications
  • Collects most recent information on new strategies for prevention and treatment of obesity and diabetes

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 274)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (23 chapters)

  1. Lifestyle Modifications and Future Treatments

    1. Physical Activity, Obesity and Weight Loss Maintenance

      • Claus Brandt, Bente Klarlund Pedersen
      Pages 349-369

    2. Bariatric/Metabolic Surgery

      • Lidia Castagneto-Gissey, James Casella-Mariolo, Geltrude Mingrone
      Pages 371-386

    3. Drugs for Treating Obesity

      • Donna H. Ryan
      Pages 387-414

    4. Novel Drugs for Diabetes Therapy

      • Tim Heise
      Pages 415-438

    5. Novel Approaches to Restore Pancreatic Beta-Cell Mass and Function

      • Alena Welters, Eckhard Lammert
      Pages 439-465

    6. Precision Medicine and Obesity

      • Daniel Sacoto, Maria Daniela Hurtado, Andres Acosta
      Pages 467-485

    7. Targeting the Enteroendocrine System for Treatment of Obesity

      • Emily L. Miedzybrodzka, Fiona M. Gribble, Frank Reimann
      Pages 487-513
Back to top

Keywords

About this book

Obesity is a major risk factor for the development of type 2 diabetes and its associated complications, a major socio-economic burden for health care systems. The worldwide prevalence of obesity doubled since 1980 and as a consequence the number of patients with diabetes has been continuously rising with more than 450 Mio. people suffering from this disease at the present time. Substantial progress has been made in understanding the molecular pathways leading from excessive fat accumulation to metabolic perturbation and finally diabetes manifestation. This edition of the "Handbook of Experimental Pharmacology" aims to analyze new insight into the pathophysiology of obesity, to decipher the complex links to diabetes and its complications, and to collect most recent information on new strategies for prevention and treatment of obesity and diabetes.

Editors and Affiliations

  • Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany

    Juergen Eckel

  • NutriOmique Research group, Nutrition Department, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université/INSERM, Paris, France

    Karine Clément

Bibliographic Information

  • Book Title: From Obesity to Diabetes

  • Editors: Juergen Eckel, Karine Clément

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-030-99995-7

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022

  • Hardcover ISBN: 978-3-030-99994-0Published: 22 July 2022

  • Softcover ISBN: 978-3-030-99997-1Published: 22 July 2023

  • eBook ISBN: 978-3-030-99995-7Published: 21 July 2022

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: VIII, 513

  • Number of Illustrations: 1 b/w illustrations

  • Topics: Pharmacology/Toxicology, Metabolic Diseases

Publish with us

Policies and ethics

Back to top

Search

Navigation